Zwi Berneman
University Hospital, Antwerp · UZA Antwerpen
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Zwi Berneman as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-11 22:41 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT06715605 · A Clinical Trial Evaluating the Safety and Efficacy of Myelin-peptide Loaded tolDC as Treatment for MSUniversity Hospital, Antwerp · withdrawn · Multiple Sclerosis · study director
- N/ANCT04053933 · Observational Study Towards the Impact of Newly Started Treatment in MDS on QoLUniversity Hospital, Antwerp · completed · Myelodysplastic Syndromes · principal investigator
- Ph1NCT02618902 · A "negative"dendritic Cell-based Vaccine for the Treatment of Multiple Sclerosis: a First-in-human Clinical TrialUniversity Hospital, Antwerp · completed · Multiple Sclerosis · study director
- Ph2NCT01686334 · Efficacy Study of Dendritic Cell Vaccination in Patients With Acute Myeloid Leukemia in RemissionZwi Berneman · active not recruiting · Acute Myeloid Leukemia · study director
- N/ANCT00845117 · Cultivated Stem Cell Transplantation for the Treatment of Limbal Stem Cell DeficiencyVeerle Van Gerwen · completed · Limbal Stem Cell Deficiency · study chair
- Ph1NCT00834002 · Dendritic Cell Vaccination for Patients With Acute Myeloid Leukemia in RemissionUniversity Hospital, Antwerp · completed · Acute Myeloid Leukemia (AML) · study director
- Ph2NCT00603330 · Mesenchymal Stem Cell Infusion as Treatment for Steroid-Resistant Acute Graft Versus Host Disease (GVHD) or Poor Graft FunctionUniversity of Liege · unknown · Graft-versus-host Disease, Poor Graft Function, Low Donor T-cell Chimerism · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-11 22:41 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 1 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-11 22:41 UTC. The ranking covers the 200 most relevant of 25 PubMed records, and a shared surname and initials can bring in a namesake. All 25 on PubMed
- Induction of complete and molecular remissions in acute myeloid leukemia by Wilms' tumor 1 antigen-targeted dendritic cell vaccination.Proc Natl Acad Sci U S A · 2010304 citationsRCR 6.4
- 228 citationsRCR 5.3
- Dendritic cell vaccination as postremission treatment to prevent or delay relapse in acute myeloid leukemia.Blood · 2017200 citationsRCR 5.8
- 172 citationsRCR 4.7
- 144 citationsRCR 4.1
- 124 citationsRCR 2.8
- 99 citationsRCR 2.0
- Results of a phase I/II clinical trial: standardized, non-xenogenic, cultivated limbal stem cell transplantation.J Transl Med · 201492 citationsRCR 3.6
- 88 citationsRCR 2.1
- 70 citationsRCR 1.6